224 related articles for article (PubMed ID: 23509295)
1. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
[TBL] [Abstract][Full Text] [Related]
2. Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.
Logan S; Anderson RE
Adv Exp Med Biol; 2014; 801():447-53. PubMed ID: 24664730
[TBL] [Abstract][Full Text] [Related]
3. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
[TBL] [Abstract][Full Text] [Related]
4. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
5. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
Bennett LD; Anderson RE
Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
[TBL] [Abstract][Full Text] [Related]
6. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
Agbaga MP; Logan S; Brush RS; Anderson RE
Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.
Logan S; Agbaga MP; Chan MD; Brush RS; Anderson RE
J Lipid Res; 2014 Apr; 55(4):698-708. PubMed ID: 24569140
[TBL] [Abstract][Full Text] [Related]
9. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors.
Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693
[TBL] [Abstract][Full Text] [Related]
10. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.
Grayson C; Molday RS
J Biol Chem; 2005 Sep; 280(37):32521-30. PubMed ID: 16036915
[TBL] [Abstract][Full Text] [Related]
12. Genetics and molecular pathology of Stargardt-like macular degeneration.
Vasireddy V; Wong P; Ayyagari R
Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366
[TBL] [Abstract][Full Text] [Related]
13. Examination of VLC-PUFA-deficient photoreceptor terminals.
Bennett LD; Hopiavuori BR; Brush RS; Chan M; Van Hook MJ; Thoreson WB; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4063-72. PubMed ID: 24764063
[TBL] [Abstract][Full Text] [Related]
14. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
[TBL] [Abstract][Full Text] [Related]
15. Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.
Okuda A; Naganuma T; Ohno Y; Abe K; Yamagata M; Igarashi Y; Kihara A
Mol Vis; 2010 Nov; 16():2438-45. PubMed ID: 21139992
[TBL] [Abstract][Full Text] [Related]
16. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
[TBL] [Abstract][Full Text] [Related]
17. ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.
Yu M; Benham A; Logan S; Brush RS; Mandal MNA; Anderson RE; Agbaga MP
J Lipid Res; 2012 Mar; 53(3):494-504. PubMed ID: 22158834
[TBL] [Abstract][Full Text] [Related]
18. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
[TBL] [Abstract][Full Text] [Related]
19. Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis?
Donato L; Scimone C; Rinaldi C; Aragona P; Briuglia S; D'Ascola A; D'Angelo R; Sidoti A
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):843-857. PubMed ID: 29417145
[TBL] [Abstract][Full Text] [Related]
20. In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4.
Mandal NA; Tran JT; Zheng L; Wilkerson JL; Brush RS; McRae J; Agbaga MP; Zhang K; Petrukhin K; Ayyagari R; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2705-13. PubMed ID: 24644051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]